Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF – Get Free Report) (TSE:CPH) shares passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $10.26 and traded as high as $10.67. Cipher Pharmaceuticals shares last traded at $10.60, with a volume of 21,458 shares changing hands.
Cipher Pharmaceuticals Stock Performance
The stock has a 50-day simple moving average of $10.26 and a 200-day simple moving average of $10.27.
Cipher Pharmaceuticals Company Profile
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company that develops, acquires and commercializes prescription products in respiratory and dermatology markets. Founded in 2004 and headquartered in Vancouver, British Columbia, the company focuses on in-licensing established therapies and launching them under its own commercial infrastructure in North America.
In the respiratory segment, Cipher markets generic inhalation therapies for conditions such as asthma and chronic obstructive pulmonary disease (COPD).
Recommended Stories
- Five stocks we like better than Cipher Pharmaceuticals
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Nike Beats on Earnings But Struggles in China and Faces Tariffs
- What is a Dividend King?
- Is the AI Boom a Bubble? These 2 Dividend Stocks Say No
- Differences Between Momentum Investing and Long Term Investing
- 4 High-Potential ETFs for 2026: Small Caps, Space Stocks, and More
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
